Energetic Abnormalities in Heart Failure With Preserved Ejection Fraction
NCT00628082 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2008-03-04
Summary
Up to half of all patients with heart failure are found to have normal pumping function of the heart muscle, but show abnormalities in the way the heart muscle relaxes and fills with blood. These patients often have high blood pressure, and tend to have stiff arteries and stiff heart muscle. We wish to test the hypothesis that these patients have abnormal energy stores in their heart muscle.
Conditions
- Heart Failure, Diastolic
Sponsors & Collaborators
-
Heart of England NHS Trust
collaborator OTHER -
British Heart Foundation
collaborator OTHER -
University Hospital Birmingham
lead OTHER
Principal Investigators
-
Michael Frenneaux, FRCP · University of Birmingham
Eligibility
- Min Age
- 40 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-03-31
- Primary Completion
- 2009-04-30
- Completion
- 2009-04-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Right Ventricular Contractile Reserve in HF
NCT05797584 ·Status: RECRUITING ·Phase: NA
-
Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function
NCT01431027 ·Status: COMPLETED
-
DNA/RNA Analysis of Blood and Skeletal Muscle in Patients Undergoing Cardiac Resynchronization Therapy (CRT)
NCT00600392 ·Status: COMPLETED
-
Tissue Doppler Assessment of Right Ventricular Performance in Acute Heeart Failure
NCT00589758 ·Status: COMPLETED
-
Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
NCT01099982 ·Status: RECRUITING
-
Leveraging Exercise Stress Echocardiography for Heart Failure With Preserved Ejection Fraction
NCT06927973 ·Status: COMPLETED ·Phase: NA
-
Exercise-induced Changes in Cardiac Function & Morphology
NCT01179802 ·Status: COMPLETED ·Phase: NA
-
The Cardiovascular Genetic and Therapeutic Implications of Muscular Dystrophy
NCT00518817 ·Status: UNKNOWN
-
Myocardial Perfusion and Contractile Reserve in End-stage Renal Disease
NCT04172064 ·Status: COMPLETED
-
Perfusion Abnormalities in Hypertrophic Cardiomyopathy
NCT06599229 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Aterial Stiffness on Myocardial Work in Patients With Hypertension
NCT04573257 ·Status: UNKNOWN
-
Non-invasive Evaluation of Myocardial Stiffness by Elastography
NCT02537041 ·Status: COMPLETED ·Phase: NA
-
Biomarkers for Human Heart Failure
NCT03905252 ·Status: COMPLETED
-
Predicting Heart Failure Outcomes With Biomarkers and Imaging
NCT07332520 ·Status: COMPLETED
-
Improving Diagnostic Accuracy for Acute Heart Failure
NCT04886128 ·Status: ACTIVE_NOT_RECRUITING
-
The Prognostic Significance of Fibrosis Detection in Cardiomyopathy
NCT00930735 ·Status: UNKNOWN
-
Prospective Becker-Heart-Study
NCT02020954 ·Status: UNKNOWN
-
Biomarkers in Aortic Stenosis - B.A.S.S.
NCT01334801 ·Status: COMPLETED
-
Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
NCT00181259 ·Status: RECRUITING
-
Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis
NCT04882488 ·Status: RECRUITING
-
Cardiac Amyloidosis in HFpEF
NCT04587648 ·Status: RECRUITING
-
PRIMA-HF: Predicting Myocardial Recovery in Heart Failure Using Cardiac Imaging HAI-HF: High Dosing vs. Standard Dosing Adenosine During Myocardial Perfusion in Heart Failure
NCT07243119 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy
NCT02994615 ·Status: COMPLETED
-
Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
NCT02922517 ·Status: UNKNOWN
-
Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy
NCT03843255 ·Status: ACTIVE_NOT_RECRUITING